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Abstract
Recessive osteogenesis imperfecta (OI) is caused by defects in proteins involved in post-
translational interactions with type I collagen. Recently, a novel form of moderately severe OI
caused by null mutations in TMEM38Bwas identified. TMEM38B encodes the ERmembrane
monovalent cation channel, TRIC-B, proposed to counterbalance IP3R-mediated Ca
2+
release from intracellular stores. The molecular mechanisms by which TMEM38Bmutations
cause OI are unknown.We identified 3 probands with recessive defects in TMEM38B. TRIC-
B protein is undetectable in proband fibroblasts and osteoblasts, although reduced
TMEM38B transcripts are present. TRIC-B deficiency causes impaired release of ER luminal
Ca2+, associated with deficient store-operated calcium entry, although SERCA and IP3R
have normal stability. Notably, steady state ERCa2+ is unchanged in TRIC-B deficiency, sup-
porting a role for TRIC-B in the kinetics of ER calcium depletion and recovery. The disturbed
Ca2+ flux causes ER stress and increased BiP, and dysregulates synthesis of proband type I
collagen at multiple steps. Collagen helical lysine hydroxylation is reduced, while telopeptide
hydroxylation is increased, despite increased LH1 and decreased Ca2+-dependent FKBP65,
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respectively. Although PDI levels are maintained, procollagen chain assembly is delayed in
proband cells. The resulting misfolded collagen is substantially retained in TRIC-B null cells,
consistent with a 50–70% reduction in secreted collagen. Lower-stability forms of collagen
that elude proteasomal degradation are not incorporated into extracellular matrix, which con-
tains only normal stability collagen, resulting in matrix insufficiency. These data support a role
for TRIC-B in intracellular Ca2+ homeostasis, and demonstrate that absence of TMEM38B
causes OI by dysregulation of calcium flux kinetics in the ER, impacting multiple collagen-
specific chaperones and modifying enzymes.
Author Summary
Osteogenesis imperfecta (OI) is a heritable disorder of connective tissues characterized by
fracture susceptibility and growth deficiency. Most OI cases are caused by autosomal domi-
nant mutations in the genes encoding type I collagen, COL1A1 and COL1A2. Delineation
of novel gene defects causing dominant and recessive forms of OI has led to the under-
standing that the bone pathology results not only from abnormalities in type I collagen
quantity and primary structure, but also from defects in post-translational modification,
folding, intracellular transport and extracellular matrix incorporation. Recently, mutations
in TMEM38B, which encodes the integral ER membrane K+ channel TRIC-B, have been
identified as causative for the OI phenotype. However, the mechanism by which absence of
TRIC-B causes OI has not been reported. Using cell lines established from three indepen-
dent probands, we have demonstrated that absence of TRIC-B leads to abnormal ER Ca2+
flux and store-operated calcium entry (SOCE), although ER steady state Ca2+ is normal.
Disruption of intracellular calcium dynamics alters the expression and activity of multiple
collagen interacting chaperones and modifying enzymes within the ER. Thus TRIC-B defi-
ciency causes OI by dysregulation of collagen synthesis, through the impairment of cal-
cium-dependent gene expression and protein-protein interactions within the ER.
Introduction
Osteogenesis imperfecta (OI), also known as “brittle bone disease”, is a heritable disorder of
connective tissue characterized by short stature, bone deformity, and susceptibility to fracture
from minimal trauma due to reduced strength and increased brittleness of bone [1]. OI occurs
in approximately 1 in 15,000–20,000 births and ranges in severity from a sub-clinical, osteope-
nic phenotype to perinatal lethality, as described by the Sillence Classification [2]. The majority
of cases (85%) result from dominant mutations in the genes that encode type I collagen,
COL1A1 and COL1A2. The less prevalent forms of OI, which mostly have recessive inheritance,
are caused by mutations in genes whose products are involved in co- and post-translational
interactions with type I collagen [3]. Although defects in more than 17 genes have now been
implicated as causative for the OI phenotype, the underlying bone pathology results from
abnormalities in type I collagen quantity, primary structure, post-translational modification,
folding, intracellular transport and extracellular matrix incorporation, thereby delineating OI
as a collagen-related bone disorder [4].
Type I collagen is the major component of the scaffolding of the extracellular matrix of skin,
tendon and bone [5]. It is synthesized by fibroblasts and osteoblasts as a heterotrimer contain-
ing a central helical region consisting of 338 uninterrupted repeats of the Gly-Xaa-Yaa triplet,
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flanked by globular domains at each terminus. Biosynthesis of procollagen is a complex process
that requires several co- and post-translational modifications within the endoplasmic reticu-
lum (ER), including formation of inter- and intra-chain disulfide bonds within the C-terminal
globular region, isomerization of peptidyl-prolyl bonds, hydroxylation of multiple helical lysyl
and prolyl residues by lysyl hydroxylase (LH1) and prolyl 4-hydroxylase (P4H), respectively,
and glycosylation of some hydroxylysines [6]. In addition, two specific proline residues are
modified by the prolyl 3-hydroxylase (P3H) complex [7,8]. The post-translational modifica-
tions occur before, and to a major extent enable, proper collagen helical folding. Upon secre-
tion from the cell, the globular domains are removed by specific pericellular propeptidases,
followed by incorporation of the mature collagen molecule into heterotypic fibrils that are sta-
bilized by lysine-derived intermolecular crosslinks [9–11].
Synthesis of type I collagen is a calcium-regulated process. Ca2+ binding to the C-terminal
globular domain stabilizes interchain hydrogen and disulfide bonds required for procollagen tri-
merization and folding [12]. Furthermore, the activities of several Ca2+-binding chaperones, fol-
dases and modifying enzymes in the ERmay be regulated by fluctuations in lumenal [Ca2+],
which are mediated through calcium release by inositol triphosphate receptors (IP3R) or ryano-
dine receptors (RyR), and calcium uptake by the sarcoplasmic-ER Ca2+-ATPase type 2b (SER-
CA2b) [13–15]. IP3R activity may also be linked to the regulation of collagen expression via
[Ca2+]i signaling pathways [16–18], while the ER membrane translocon complex component,
TRAM2, is suggested to couple SERCA2b activity with translation of type I procollagen chains
[19]. Thus, disruption of ER Ca2+ homeostasis has the potential to alter the expression and activi-
ties of multiple collagen interacting proteins and dysregulate the process of collagen biosynthesis.
Recently a novel form of recessive OI, caused by a founder mutation, was reported in Bed-
ouin families from Israel and Saudi Arabia [20,21]. The probands from these families presented
with a moderately severe bone phenotype, characterized as type XIV OI (OMIM #615066),
with bowing and fragility of long bones leading to multiple fractures in infancy. Two groups
independently identified the same mutation in TMEM38B, a deletion of exon 4 and surround-
ing intronic sequence [20,21]. A second deletion mutation was identified in an Albanian child,
born to consanguineous parents, who harboured a genomic deletion including exons 1 and 2
of TMEM38B [22]. Homozygosity for two point mutations in TMEM38B was recently reported
in three probands from non-consanguineous Han Chinese families, including a splice acceptor
site variant in intron 3 and a nonsense mutation in exon 4 [23].
TMEM38B encodes the ER membrane TRimeric Intracellular Cation channel subtype B
(TRIC-B), a ubiquitous protein that functions as a monovalent cation channel. The TRIC-B
channel has been proposed to affect Ca2+ homeostasis in the ER, the major site of intracellular
Ca2+ storage [24]. Although TMEM38B null mutations were demonstrated to be the genetic
cause of moderately severe bone dysplasia, the molecular mechanisms through which absence
of TRIC-B causes an OI phenotype are unknown. We identified three additional probands
with TMEM38Bmutations and investigated the effects of absence of TRIC-B on intracellular
[Ca2+] flux and collagen biosynthesis. Our findings demonstrate that TRIC-B deficiency dysre-
gulates multiple steps in collagen biosynthesis, placing the mechanism of TRIC-B absence
within the collagen-related paradigm of OI.
Results
Mutations in TMEM38B cause recessively inherited Osteogenesis
Imperfecta
Proband 1 (P1), a 20-month old female, was the second child with moderately severe OI born
to apparently healthy consanguineous parents from Saudi Arabia (Fig 1A). Since a recurring
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Fig 1. TMEM38Bmutations cause recessive Osteogenesis imperfecta. (A) Pedigree of a four-generation consanguineous Saudi family, including
Proband 1 (P1, arrow) and her affected sibling diagnosed with moderate OI (Type IV). (B) PCR amplification of genomic DNA using allele-specific primers
(arrows) located adjacent to and within the previously identified TMEM38B deletion (dashed lines) in Bedouin pedigrees. Control genomic DNA (C)
generated the expected 499 bp fragment (NL). In contrast, amplification of proband genomic DNA (OI) produced only a single 821 bp product (MUT),
consistent with homozygosity for the Bedouin founder mutation, and confirmed by sequencing. (C) Family pedigree of Proband 2 (P2, arrow) and his
affected sibling. (D) Sequence of TMEM38B exon 1 demonstrates apparent homozygosity in P2 (OI) and his affected sibling (S) for the maternal allele
(c.63dupTmutation). While the mother (M) was heterozygous for the single nucleotide duplication, only the normal sequence was identified in the father
(F). (E) The paternal allele in P2 is identical to a previously identified 35 Kb deletion encompassing the first two exons of TMEM38B. Heminested PCR of
genomic DNA using allele-specific primers (arrows) confirmed the father (F), P2 (OI) and his sibling (S) as heterozygous for the paternal allele (MUT). (F)
Pedigree of consanguineous Pakistani family including Proband 3 (P3) (G) Sequences of TMEM38B exon 4 using genomic DNA of P3 (OI) and normal
control DNA (NL) demonstrates a homozygous nonsense mutation (c.507G>A).
doi:10.1371/journal.pgen.1006156.g001
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deletion mutation of exon 4 and the surrounding intronic region of TMEM38B was previously
identified in Bedouin populations from Israel and Saudi Arabia, we focused on this gene for
P1. Nested primers designed to separately detect the specific products from the normal and
mutant TMEM38B alleles were utilized for PCR amplification, with the expected fragment
from the normal allele being detected only in the control sample (Fig 1B). Primers targeting
exon 4 failed to amplify P1 gDNA. However, primers flanking the previously reported deletion
generated a single 821 bp fragment, consistent with homozygosity for the Bedouin founder
mutation, and verified by Sanger sequencing as TMEM38B g.32476_53457delins ATTAAGG-
TATA (Fig 1B).
Proband 2 (P2), a 27-year old American male of English, Scottish and German descent, is the
first of two affected children born to nonconsanguineous parents (Fig 1C). His moderately
severe OI was diagnosed using the combination of NGS OI gene panels and TMEM38B copy
number analysis. The initial screening of proband genomic DNA identified an apparently
homozygous TMEM38Bmutation (c.63dupT), which directly introduces a premature termina-
tion codon (PTC) in exon 1 (p.D22X). However, only the mother could be confirmed as a car-
rier for this mutation, while both alleles appeared normal at this site in his father (Fig 1D),
suggesting the presence of a paternal TMEM38B deletion encompassing exon 1. Subsequent
copy number analysis and hemi-nested PCR was used to identify in P2’s father the same dele-
tion previously reported in an Albanian proband, extending from approximately 35 Kb
upstream of the start codon to intron 2 of TMEM38B [22]. Both affected siblings and the father
were confirmed to harbour this mutation, GRCh38 chr9:g.105,682,311_105,716,202del (Fig 1E).
Proband 3 (P3) is a 13-year old male born to consanguineous Pakistani parents residing in
Britain (Fig 1F). Following his clinical diagnosis of moderately severe OI, molecular screening
using an NGS OI sequencing panel identified the proband as homozygous for a TMEM38B
c.507G>A point mutation, predicted to introduce a PTC in exon 4 (p.W169X) (Fig 1G), and
identical to that recently reported by Lv, et al [23]. A complete clinical description of Proband
2 and Proband 3’s phenotype, bone structural and histomorphometric parameters will be pub-
lished elsewhere.
The TMEM38Bmutations result in functional null alleles
To determine whether the molecular defects result in generation of abnormal protein products
or null alleles, we characterized TMEM38B transcripts and TRIC-B protein produced by pro-
band fibroblasts (P1-3) and osteoblasts (P2). By quantitative RT-PCR we found that
TMEM38B transcripts from Proband 1 cells were reduced to approximately 36 ± 3% of normal
control (Fig 2A). P1 TMEM38B transcript level was rescued by treatment of cells with emetine,
suggesting nonsense-mediated decay (NMD) of transcripts containing premature termination
codons (PTCs) (Fig 2A). In agreement, RT-PCR analysis of proband total RNA generated mul-
tiple fragments, rather than the normal 639 bp fragment (Fig 2B). Five alternatively spliced
transcripts were identified, four of which contain PTCs and one in-frame transcript that was
expressed at approximately 8% the level of TMEM38B transcripts from control cells (S1A and
S1B Fig).
Proband 2 TMEM38B transcripts were 86 ± 7% and 66 ± 6% of normal controls in
untreated fibroblasts and osteoblasts, respectively (Fig 2A). Since the real-time RT-PCR assay
used to quantitate TMEM38B expression spans exons 1 and 2, the transcripts detected in P2
cells must originate from the maternal allele, which appears to be capable of significant com-
pensation despite the presence of a PTC. Proband 3 fibroblasts, similar to P1, demonstrated
severely reduced transcripts (19 ± 2%) compared to normal control cells, which could be res-
cued by emetine treatment (Fig 2A).
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Although residual TMEM38B transcripts were present in proband cells, total absence of
TRIC-B protein was demonstrated in all proband fibroblast and osteoblast lysates (Fig 2C). In
normal control fibroblasts and osteoblasts TMEM38A transcripts were detected at 2–4% of the
levels of TMEM38B and occurred at equivalent levels in proband cells (S2A Fig), suggesting that
TRIC-B is the primary TRIC isoform in these cells. These results establish that the TMEM38B
mutations identified in our three probands result in functionally null alleles, and its absence is
not compensated by increased TRIC-A expression in human fibroblasts and osteoblasts.
TRIC-B deficiency alters intracellular calcium levels and flux
In non-excitatory cells, ER Ca2+ homeostasis is maintained by SERCA2b, responsible for Ca2+
uptake, and IP3R, which releases Ca
2+ stores into the cytoplasm. To verify a role for TRIC-B in
ER calcium mobilization, we used a cytoplasmic UV-excitable Ca2+ indicator to analyze cal-
cium release from the ER in normal and proband fibroblasts and osteoblasts. In Ca2+-free
media under steady-state conditions, cytoplasmic [Ca2+]i was decreased approximately 40–
50% in proband versus normal control cells (Fig 3A), implying a defect in store-operated cal-
cium entry into cells. When IP3R-mediated release of Ca
2+ stores was stimulated with ATP,
release of Ca2+ from the ER was reduced in proband cells (Fig 3B and 3C). Furthermore, iono-
mycin-induced Ca2+ release from all intracellular stores was also reduced in proband
Fig 2. The TMEM38Bmutations result in null alleles. (A) Real-time RT-PCR analysis of TMEM38B transcripts from control (C) and proband (P1, P2
and P3) fibroblasts and osteoblasts. Rescue of transcripts by treatment of cells with emetine (+) indicates inhibition of nonsense-mediated decay due to
the presence of premature termination codons (PTCs). **, p < 0.01. (B) RT-PCR analysis of TMEM38BmRNA from control (C) and P1 (OI) fibroblasts in
the absence or presence emetine. Several unique amplification products were observed for P1 samples, including multiple splice variants and
heteroduplexes (HD), as detailed in S1 Fig. (C)Western analysis of control (C) and proband (P1, P2 and P3) fibroblast and osteoblast lysates indicates
absence of TRIC-B protein in proband cells.
doi:10.1371/journal.pgen.1006156.g002
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Fig 3. Absence of TRIC-B dysregulates ER Ca2+ homeostasis. (A) Basal levels of [Ca2+]i in control (C) and proband fibroblasts (P1, P2) and
osteoblasts (P2). (B) Decreased Ca2+ mobilization in TRIC-B deficient fibroblasts (red lines). ATP- and Ionomycin-stimulated Ca2+ release, as well as
the return to baseline levels, are decreased in proband (P2) cells. (C) Decreased Ca2+ mobilization in TRIC-B deficient osteoblasts (red lines). (D) The
intracellular Ca2+ stores available for IP3R-mediated release are more rapidly depleted in Proband 1 fibroblasts (right) versus normal control cells (left).
ATP-stimulated Ca2+ release is abrogated within 10 minutes in proband cells compared to 30 minutes in control cells following inhibition of SERCA
channels with thapsigargin (TG). (E)Measurement of ER luminal Ca2+ using ER-localized Ca2+ indicator. Each point represents the average of one
measurement containing 1–7 cells. The difference between the steady-state and Ca2+-depleted FRET signal emitted by the D1ER chameleon class
Ca2+ sensor was equivalent in normal control and proband cells. (F)Quantitative RT-PCR in control (C) and proband (P1, P2, P3) cells. There is no
significant difference in expression levels of SERCA2 (ATP2A2) and IP3R1 (ITPR1) in fibroblasts, but transcripts are significantly reduced in proband
(P2) osteoblasts. (G) Immunoblots of control (C) and proband (P1, P2, P3) cell lysates demonstrate equivalent levels of SERCA2b and IP3R1 Ca2+
channels. *, p < 0.05; **, p < 0.01.
doi:10.1371/journal.pgen.1006156.g003
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fibroblasts and osteoblasts. The Fura-2 Ca2+ indicator signal in proband cells also required a
longer period of time to return to baseline than in control cells (Figs 3B, 3C and S3). We further
confirmed that Ca2+ release from the ER was defective in the absence of TRIC-B by inhibiting
Ca2+ uptake with thapsigargin. ER Ca2+ release was depleted in P1 fibroblasts within 10 min-
utes of inhibition versus 30 minutes in control cells (Fig 3D).
To determine whether the decreased Ca2+ flux in TRIC-B deficient cells was associated with
abnormal [Ca2+] steady state levels within the ER, we measured free ER [Ca2+] using the tar-
geted ratiometric calcium sensor D1ER [25,26]. Interestingly, there was no measurable change
in ER luminal free [Ca2+] in proband or normal control cells following ATP treatment, suggest-
ing that the amount of stored Ca2+ needed to elevate cytoplasmic Ca2+ is minor compared to
total Ca2+ available in the ER. Furthermore, no significant differences in the baseline (before
ATP treatment) and depleted (after ionomycin treatment) ER Ca2+ signals were observed
between normal control and proband cells (Fig 3E). This indicates that TRIC-B deficiency does
not result in an altered steady state luminal ER free [Ca2+] as, for example, a result of the
abnormal [Ca2+] flux. Luminal ER free [Ca2+] is neither decreased nor increased.
Although ER Ca2+ homeostasis was dysregulated in proband cells, transcript levels for
ATP2A2 (ATPase Ca2+ transporting cardiac muscle slow twitch 2, SERCA2) and ITPR1
(IP3R1) were normal in proband fibroblasts (Fig 3F). In contrast, in P2 osteoblasts both
ATP2A2 and ITPR1 expression were decreased to 55 ± 4% and 16 ± 5%, respectively, of normal
control osteoblasts. However, no consistent significant difference in SERCA2b or IP3R1 protein
was detected in proband cells compared to control (Fig 3G). Expression of RYR1, encoding the
ryanodine receptor for Ca2+ release in excitatory cells, was found to be 0.2–1.0% the level of
ITPR1 expression in normal control and proband fibroblasts and osteoblasts (S2B Fig).
TMEM38B-null cells display ER stress
Inhibition of the ER calcium pump (SERCA) is known to trigger an ER stress response in vari-
ous cell types. We examined the three main signaling pathways activated in the unfolded pro-
tein response (UPR) [27], and observed a stress response in TRIC-B deficient cells upon
stimulation of procollagen synthesis with ascorbate (Fig 4). Activating transcription factor 4
(ATF4) protein was increased 66–122% in proband fibroblasts versus normal control cells (Fig
4A), suggesting that the PERK-dependent pathway of the UPR is likely activated in these cells.
Furthermore, ATF4 is known to interact with theHSPA5 (BiP/GRP78, immunoglobulin bind-
ing protein/78 kDa glucose-regulated protein) promoter [28], consistent with our findings that
HSPA5 transcripts and BiP protein were increased 45–122% and 145–332%, respectively, in
proband fibroblasts, and associated with a 250% increase in BiP in P2 osteoblasts compared to
normal control osteoblasts (Fig 5A–5C). In contrast, cleavage of ATF6 by Site 1- (S1P) and
Site-2 proteases (S2P) and IRE1-mediated splicing of XBP1 were both found to be equivalent
in proband and normal control cells by western and RT-PCR analyses (Fig 4A and 4B).
TRIC-B deficiency affects collagen-modifying enzymes
We next investigated the effects of TRIC-B deficiency on collagen-modifying enzymes in pro-
band cells (Fig 5A–5C). Expression studies of proteins previously demonstrated to be calcium-
dependent revealed that FK506 binding protein 10 (FKBP10) transcripts were reduced 31–46%
versus normal controls, and its protein product FKBP65, which is stabilized by Ca2+ and is
required for collagen telopeptidyl hydroxylation and crosslinking, was decreased approxi-
mately one-half in proband fibroblasts and osteoblasts versus matched normal control cultures.
We found additional alterations in the expression of genes that have not previously been dem-
onstrated to require calcium for stability or function. Procollagen-lysine, 2-oxoglutarate
Absence of TRIC-B Dysregulates ER Calcium Homeostasis and Causes OI
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5-dioxygenase 1 (PLOD1) transcripts were increased 50–360% and its protein product, lysyl
hydroxylase 1 (LH1), was increased 123–180% in proband fibroblasts and 70% in osteoblasts,
compared to matched normal control cells. PLOD2 transcripts were decreased 30–40% in P1
and P3 fibroblasts, and 15% in P2 osteoblasts, but LH2 protein was found to be increased 25–
600% in proband fibroblasts and 100% in osteoblasts versus matched normal control cells.
Although no consistent changes in expression were observed for protein disulfide isomerase/
prolyl 4-hydroxylase subunit beta (PDI/P4HB) or Cyclophilin B (CyPB/PPIB) transcripts, we
found consistent alterations in PDI and CyPB protein levels. Immunoblots demonstrated that
proband cell lysates contained 48–124% more PDI protein versus matched normal control
cells. In contrast, CyPB protein was decreased 17–50% versus matched controls.
TRIC-B deficiency alters collagen post-translational modification and
assembly
Given the alterations in collagen-interacting protein levels in proband cells, we examined type
I collagen modification and folding. PDI (P4HB) catalyzes the formation and rearrangement of
Fig 4. TRIC-B deficiency activates ER stress. (A) Immunoblots of steady-state cell lysates demonstrate
equivalent levels of ATF6 (N, nuclear form) protein in proband (P1, P2, P3) versus normal control cells.
Increased ATF4 protein in proband cells is consistent with activation of the PERK pathway of the UPR, and is
similar to the increase in normal control fibroblasts treated with the SERCA inhibitor thapsigargin (THAP), but
in contrast to normal control cells treated with N-glycosylation inhibitor tunicamycin (TUNI). (B) RT-PCR
amplification of XBP1mRNA from normal control and proband (P1, P2, P3) cells. There is no difference in the
ratio of spliced (XBP-1s) to unspliced (XBP-1u) transcripts between control and proband cells, while partial
and complete splicing are detected in normal control fibroblasts treated with tunicamycin (TUNI) and
thapsigargin (THAP), respectively.
doi:10.1371/journal.pgen.1006156.g004
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disulfide bonds, which is a critical step in the initial association and folding of procollagen
alpha chains. Although we found that P4HB (PDI) expression was normal (Fig 5A and 5B),
and PDI protein levels were moderately increased (Fig 5C), there was an approximately 20
minute delay in procollagen chain assembly into heterotrimeric molecules in proband fibro-
blasts and osteoblasts (Fig 6A). Furthermore, following alpha chain association, CyPB facili-
tates collagen folding into a protease-resistant triple helical conformation by catalyzing the cis-
trans isomerization of collagen peptidyl-prolyl bonds. In direct intracellular collagen folding
assays, the rate of accumulation of intracellular protease-resistant type I collagen heterotrimers
Fig 5. Absence of TRIC-B alters expression of collagen-interacting proteins. (A)Quantitative RT-PCR of fibroblast transcripts encoding collagen,
modifying enzymes and chaperones. Proband cells (P1, P2, and P3) demonstrate decreased expression ofCOL1A1 and FKBP10 (FKBP65), and
increased expression ofPLOD1 (LH1) andHSPA5 (BiP/GRP78) versus control fibroblasts (C). (B)Decreased expression ofPLOD2 (LH2), FKBP10
(FKBP65) and PPIB (CyPB) in P2 osteoblasts versus control osteoblasts (C). (C) Immunoblots for quantitation of steady-state protein levels of collagen
modifying enzymes and chaperones in proband and control cells. Proband fibroblasts show increases in PDI, LH1, LH2 and BiP protein levels. CyPB and
FKBP65, both collagen-interacting isomerases, are consistently decreased in proband fibroblasts and osteoblasts. *, p < 0.05; **, p < 0.01; ***, p < 0.001.
doi:10.1371/journal.pgen.1006156.g005
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in TRIC-B-deficient cells was equivalent to control cells, indicating that the peptidyl-prolyl
isomerase function of CyPB is sufficient for normal collagen folding (S4 Fig).
In classical OI, collagen structural defects delay folding of the helix and increase the duration
of exposure to ER-resident modifying enzymes, including LH1. In contrast, LH1 deficiency in
Type VI Ehlers-Danlos (EDS VI) results in decreased modification of the collagen alpha chains.
These alterations in collagen post-translational modification can be detected as delayed or
increased electrophoretic migration, respectively, of the collagen alpha chains. Surprisingly,
despite consistent increases in transcript and protein levels of PLOD1/LH1 in TRIC-B-deficient
cells (Fig 5A–5C), helical lysine hydroxylation was reduced by approximately 20–30% in pro-
band fibroblast type I collagen (Table 1). By comparison, fibroblasts from a proband with EDS
VI synthesize type I collagen with an 86% reduction in hydroxylysine content (Table 1).
Reduced hydroxylysine content is also consistent with the more rapid electrophoretic migration
of proband type I collagen alpha chains on SDS-Urea-PAGE (Fig 6B). Type I collagen synthe-
sized by proband osteoblasts has the same increased electrophoretic mobility as proband fibro-
blast collagen, but shows a lesser extent of reduction in total hydroxylysine content compared to
published data on differentiated human bone marrow stromal cells (Table 1) [29]. The
decreased hydroxylation of collagen lysyl residues synthesized by TRIC-B deficient cells demon-
strates impaired lysyl hydroxylase function, despite increased transcript and protein levels.
Interestingly, collagen telopeptidyl hydroxylation, catalyzed by FKBP65-dependent LH2
(PLOD2), was increased despite the reduction in FKBP10 transcripts and FKBP65 protein to
Fig 6. Disruption of ER [Ca2+] homeostasis dysregulates type I collagen synthesis. (A) Intracellular chain association assay to follow assembly of
monomeric pro-α1(I) and pro-α2(I) chains into heterotrimeric procollagen molecules, α1(I)2α2(I), at 20 minute intervals of a pulse-chase analysis.
Unincorporated pro-α1(I) chains are present in proband cells approximately 20 minutes longer in P1 fibroblasts (P1 FB) and P2 (P2 OB) osteoblasts
versus normal control fibroblasts and osteoblasts (C). (B) Steady-state cell layer (cell) and secreted (media) collagen from normal control (C) and
proband fibroblasts (P1-P3, FB) and osteoblasts (P2, OB) analyzed by SDS-Urea PAGE. Both the α1(I) and α2(I) chains of type I collagen from proband
cells demonstrate faster electrophoretic migration than normal control type I collagen alpha chains.
doi:10.1371/journal.pgen.1006156.g006
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the level of type XI OI carriers (OMIM #610968, Fig 5A–5C, Table 1) [30]. Also, modification
of proline residues in proband type I collagen catalyzed by prolyl 4-hydroxylase was normal,
while collagen prolyl 3-hydroxylation was comparable to the level found in carriers of types
VII and VIII OI (OMIM #610682, #610915, Table 1) [31,32].
Type I collagen synthesized by TRIC-B deficient cells has an abnormal
conformation
Because proband collagen post-translational modification was altered, we sought to character-
ize its structure and stability. Calorimetric analysis of secreted type I collagen showed a lower
stability fraction in proband collagen samples, with reduction in Tm ranging from 2°C in P1 to
0.5°C in P2. In P1 collagen, the lower stability fraction comprised 30–40% of total secreted pro-
band collagen (Fig 7A). In contrast, the melting curve of collagen secreted from PLOD1 (LH1)-
deficient fibroblasts (EDS VI) was similar to control collagen, demonstrating that destabiliza-
tion of collagen is not a consequence of the underhydroxylation of lysyl residues, and raising
the probability that it is a function of improper folding.
The low stability collagen synthesized in the absence of TRIC-B is susceptible to intracellu-
lar retention and proteasomal degradation. Immunoblots of cell lysates and conditioned media
demonstrated increased cell layer type I procollagen in proband fibroblasts (P1, 285 ± 64%; P2,
65 ± 25%) and osteoblasts (P2, 83 ± 24%) versus normal control cells (Fig 7B). Although no
significant difference in the total amount of cell layer procollagen was seen in normal control
cells treated with MG132, proteasomal inhibition further increased the accumulation of intra-
cellular type I procollagen in proband fibroblasts (P1, 335 ± 78%; P2, 220 ± 90%) and osteo-
blasts (P2, 355 ± 21%), with a concomitant 40 ± 10% and 57 ± 5% reduction of collagen
secreted into the media of proband fibroblasts and osteoblasts, respectively. The disproportion-
ate distribution of collagen between the cell layer and media fraction in proband cultures is
consistent with the presence of a misfolded collagen species that is predominantly retained and
degraded by ER-associated degradation (ERAD).
A fraction of the misfolded collagen eludes intracellular degradation and is secreted into the
extracellular space, although the proportion varies among probands and between osteoblasts
and fibroblasts. Pulse-chase analysis of procollagen secretion demonstrated that pericellular
processing in P1 fibroblast cultures was delayed, especially at the amino end of the pro-α1(I)
chain (S5 Fig). Since the type I procollagen amino propeptidase is a conformation-sensitive
enzyme, these results further suggest that the conformation of procollagen secreted by P1 fibro-
blasts is abnormal. The lower thermal stability, increased intracellular proteasomal degradation
and resistance to processing by endogenous enzymes support the presence of a misfolded colla-
gen species in TRIC-B-deficient fibroblasts, some of which is secreted.
Table 1. Type I procollagen post-translational modification.
NL Control FB Proband 1 FB Proband 2 FB Proband 3 FB EDS VI FB Proband 2 OB NL Control OB
% Total Hyl 22.7 ± 2.8 15.9 16.5 18.8 3.2 21.1 23.2 ± 2.5*
% Total Hyp 44.6 ± 1.3 47.0 43.1 36.4 53.0 41.5 44.5 ± 0.7*
% α1(I) P986 3-Hyp 95.5 ± 1.5 89 83 88 91 95
% α1(I) N-telo Hyl 17 26 32 37 26 27
% α2(I) N-telo Hyl 69 84 100 100 100 100
% α1(I) C-telo Hyl 62.3 ± 3.7 86 64 85 100 100
* Values for fully differentiated human BMSC cultures previously reported by Uzawa, et al [29].
doi:10.1371/journal.pgen.1006156.t001
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Decreased synthesis, secretion and deposition of abnormal Type I
collagen causes extracellular matrix insufficiency
Given the abnormal collagen post-translational modification and conformation, we investi-
gated the effects of TRIC-B deficiency on collagen secretion and incorporation into extracellu-
lar matrix deposited in culture. The intracellular retention and degradation results in a 50–75%
(p< 0.01) decrease in collagen secretion from proband versus control fibroblasts and
Fig 7. Collagen conformation and secretion are altered by abnormal ER [Ca2+]. (A) Differential scanning calorimetry (DSC) analysis reveals no
differences in thermal stability (Tm) of type I collagen secreted by control (C, media) and LH1-deficient (EDS VI, media) fibroblast cultures, but a low-
stability fraction in proband (P1, P2, media) secreted collagen. Thermal stability of type I collagen extracted from extracellular matrix deposited in
culture by control (C, matrix) and proband (P1, P2, matrix) cells is equivalent. (B) Immunoblots of intracellular (cell) and secreted (media) type I
collagen from control (C) or proband (P1, P2) fibroblasts (FB) and osteoblasts (OB, P2) cultured in the absence or presence of proteasomal inhibitor
(MG132). Retention of type I collagen in proband cells is increased upon treatment. (C)Quantitation of total procollagens in 24 hour conditioned
media of control (C) and proband cell cultures. Secretion of procollagens is decreased by more than one-half in proband fibroblasts (P1, P2, P3) and
osteoblasts (P2). **, p < 0.01; ***, p < 0.001.
doi:10.1371/journal.pgen.1006156.g007
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osteoblasts, as quantitated in 24-hour conditioned media (Fig 7C). The decreased amount of
procollagen secreted by proband cells did not reflect a delay traversing the secretory pathway,
as the secretion rate was normal. Rather, total type I procollagen synthesized by P1 fibroblasts
was decreased by 38 ± 7% (p< 0.01) compared to normal control cells (S6 Fig).
The low stability collagen species identified by DSC in the media of P1 fibroblast cultures
was not incorporated into extracellular matrix deposited in culture, which contained only col-
lagen with normal thermal stability (Fig 7A), and was associated with a 35 ± 5% reduction of
crosslinked collagen in matrix (S7 Fig). Thus, reduced secretion of total procollagen, exacer-
bated by the presence of misfolded collagen species that are resistant to incorporation into
extracellular matrix, together contribute to matrix insufficiency.
Discussion
TMEM38B, encoding the integral ER membrane protein TRIC-B, was first identified as a novel
gene causing autosomal recessive OI among consanguineous Bedouin kindreds from Saudi
Arabia and Israel, who harboured a homozygous exon 4 deletion mutation [20,21]. A second
homozygous deletion mutation, encompassing the first two exons of TMEM38B, was identified
in an Albanian proband [22]. And two point mutations, affecting either the intron 3 splice
acceptor site or an exon 4 nonsense mutation, were reported in Chinese Han probands. [23].
The three cases reported in this investigation involved three of the four previously reported
TMEM38Bmutant alleles, and one additional independent TMEM38Bmutation in a family of
English/Scottish background, all resulting in total absence of TRIC-B protein due to nonsense
mutations. Patients with type XIV OI have low bone volume associated with low bone turnover
and relatively normal bone matrix mineralization, features that set this OI type apart from the
high bone turnover and increased mineralization found in classical OI. Here, we utilized the
TMEM38B-null primary fibroblasts and osteoblasts from our probands to characterize the
mechanism by which absence of TRIC-B causes moderately severe OI.
This report also presents the first demonstration in humans of abnormal ER Ca2+ homeo-
stasis due to the absence of TRIC-B. In proband primary fibroblasts and osteoblasts we found
that both cytoplasmic [Ca2+] and IP3R-mediated Ca
2+-flux were decreased in Ca2+-free media,
genetically validating a role for TRIC-B in maintaining intracellular Ca2+ levels [24]. Ionomy-
cin-induced Ca2+ flux from the ER into the cytoplasm was weaker in proband cells. Deficient
Ca2+ release from the ER was also found after ER calcium pumps were irreversibly inhibited
with thapsigargin; the calcium available for release from the ER was depleted more rapidly
from TRIC-B deficient than from control cells. The decreased cytoplasmic Ca2+ in TMEM38B-
deficient cells suggested Ca2+ transport processes at the cell membrane may also be altered.
Calcium entry into the cell by a process of “store-operated calcium entry” (SOCE) may be sec-
ondarily defective in TMEM38B-deficient cells, possibly due to defective function of the ER
Ca2+ sensor STIM protein [33]. Interestingly, the steady state ER Ca2+ measurement in live
cells with the direct ER sensor D1ER was neither increased nor decreased compared to control.
This data implies that cells with chronic TRIC-B deficiency make compensatory adjustments
in ER calcium uptake, such as upregulation of stimulated Ca2+ release channel function, which
may also underlie the rapid Ca2+ depletion seen with the cytoplasmic Fura-2 probe on ATP
stimulation. Taken together, the type XIV OI ER and flux data support a role for TRIC-B chan-
nels when calcium release channels are closed, presumably by assuring a slow return to normal
ER potassium homeostasis. Deficiency of TRIC-B likely slows ER Ca2+ recovery more than it
affects ER Ca2+ steady state.
Studies of TRIC-A and TRIC-B function in murine cells, cardiomyocytes or type II alveolar
cells have led to two proposals for the TRIC-B contribution to ER Ca2+ homeostasis. In one
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model, Takeshima and colleagues proposed that TRIC-A channels selectively provide K+ coun-
tercurrents in support of RyRs, while TRIC-B serves to support IP3R-mediated Ca
2+ release
[34]. Murine Tricb -/- type II alveolar cells demonstrated decreased intracellular resting Ca2+
levels and weakened ATP-induced IP3R-mediated Ca
2+ release, but increased Ca2+ responses
to ionomycin in comparison to wild-type cells when the calcium indicator is loading in the
presence of Ca2+ [35]. They proposed that a state of ER Ca2+ overload exists when TRIC-B is
absent. In a second model, Fill and colleagues proposed that the major Ca2+/K+ countercurrent
occurs directly through RyR and IP3Rs, rather than through TRIC channels [36]. This group
also observed no change in ER Ca2+ activity when TRIC function was acutely limited [37].
Instead, TRIC channels would function to maintain the K+ steady state when Ca2+ release
channels are not gating [37]. Hence, if TRIC-B is a calcium sensor that detects a differential
[Ca2+]i between the cytosol and lumen [38], then ER calcium replenishment would be defective
in the absence of TRIC-B. Our experiments detected no genetic support for the ER Ca2+ over-
load model in osteoblasts, and are rather consistent with a role for TRIC-B in modulating the
kinetics of Ca2+ flux. Although the osteoblast cell line MC3T3-E1 has been reported to have
functional IP3R and RyR receptors for Ca
2+ release [39], we found negligible expression of
RyR, and minimal TRIC-A expression (2–5% of TRIC-B) in proband cells. In murine lung
cells, TRIC-A protein is several-fold lower than TRIC-B [35]. Thus, the difference between
mouse alveolar type II cells and human fibroblasts/ osteoblasts may represent cell- or species-
specific redundancy of channels for Ca2+ flux.
Inhibition of the ER calcium SERCA-pump elicits a stress response in mammalian cells,
characterized by dissociation of BiP from PERK, IRE1 and ATF6 [40–42]. We found that the
abnormal Ca2+ flux in TRIC-B deficient cells increased ATF4, consistent with PERK activation,
but not IRE1 and ATF6. The PERK branch of the UPR has been proposed to mediate cellular
responses to calcium concentration, and may function as an ER Ca2+ sensor [43].
Why do null mutations for TMEM38B cause osteogenesis imperfecta, which is a collagen-
related condition? We show here that disrupted ER-Ca2+ flux kinetics in TMEM38B-null cells is
associated with altered expression and activity of multiple collagen modifying enzymes and
chaperones, resulting in abnormal post-translational modification and folding of type I collagen
(Fig 8). We found abnormal levels and/or functioning of collagen-interacting proteins BiP, PDI
and CyPB in patient cells. The delay in trimeric procollagen chain assembly in proband cells
suggests that the ability of PDI to catalyze disulfide formation may be compromised, despite the
increased quantities of PDI protein in proband cells. Because of slow Ca2+ flux kinetics, PDI
may be sequestered by binding to calreticulin [14,44], and have reduced availability for collagen
folding. CyPB, a member of the procollagen 3-hydroxylation complex in the ER, was also con-
sistently decreased in proband cells, although not below the level expected of an unaffected het-
erozygous carrier of a PPIB defect [30]. Proband type I collagen shows moderately decreased
3Hyp levels, similar to heterozygous carriers of null mutations P3H1 and CRTAP (Table 1)
[31,32,45], implying some impairment in complex function. In addition, CyPB’s role as a bind-
ing partner for multiple ER chaperones and foldases may be impaired in TMEM38B-null cells.
CyPB binds both BiP and PDI, as well as a number of other ER partners, through a lysine-rich
site distinct from the isomerase catalytic site inhibited by cyclosporin A (CsA). The partner pro-
teins bind to CyPB through an N-terminal acidic motif that has also been suggested to be a cal-
cium-binding site [46]. Interactions between CyPB and its partners have been speculated to
concentrate both proteins on shared substrates [46], and disruption of these interactions in an
altered ER [Ca2+] environment might modulate their joint role. In contrast, we detected no
delay in collagen folding, which is dependent on the PPIase function of CyPB [47].
The most striking alteration in collagen modification is the reduction in hydroxylysine con-
tent of proband collagen, presumably due to dysfunction of LH1, despite the attempted cellular
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compensation of increased PLOD1 transcripts and increased LH1 protein. In vitro, only high
non-physiologic [Ca2+] levels were found to decrease the activity of purified LH1 [48]. In vivo,
LH1 protein has been shown to interact directly with CyPB and SC65/P3H3 [47,49,50]. Since
LH1 dysfunction in TMEM38B-null cells cannot be attributed to absence of the PPIase func-
tion of CyPB, it raises the speculation that LH1 and CyPB might have an additional Ca2+-regu-
lated interaction, similar to that demonstrated for other chaperones. The collagen lysine
hydroxylation defect in TMEM38B-null cells may be more selective for certain residues in oste-
oblast than fibroblast collagen. Residue-specific alteration of lysine hydroxylation in fibroblasts
and osteoblasts occurs in Ppib-null and Sc65-null mice [49,50]. Because data on lysine modifi-
cation of collagen from normal human primary osteoblasts is not available, we compared our
proband’s osteoblast collagen to published data from differentiated human bone marrow stro-
mal cells (BMSC) [29], which may vary in modification from collagen synthesized by primary
osteoblasts. Regardless, the altered hydroxylysine content of collagen synthesized by
TMEM38B-null patient cells would reduce the residues available for crosslinking of collagen
molecules in matrix, which contributes to matrix stability, bone strength and ductility [51,52].
Interestingly, although the immunophilin FKBP65, which is stabilized by Ca2+ and modifies
collagen telopeptidyl residues involved in crosslinking by LH2 [53,54], was decreased in pro-
band cells, collagen telopeptidyl hydroxylysine content was moderately increased. This likely
reflects slower collagen assembly in the presence of sufficient residual FKBP65 activity.
In summary, our data demonstrate that absence of TRIC-B from fibroblasts and osteoblasts
of patients with type XIV OI impairs ER [Ca2+] flux kinetics. We identified dysregulation of
Fig 8. Calcium flux regulates collagen post-translational interactions within the ER. Secreted proteins such as collagen
are synthesized within the ER, which contains the major intracellular Ca2+ store. In response to extracellular stimuli, Ca2+ is
released from the ER lumen into the cytoplasm via IP3 and ryanodine receptors. Cytoplasmic Ca
2+ that does not bind signaling
proteins involved in gene expression is transported back into the ER via SERCA pumps. The continuous fluctuations in free
[Ca2+] to and from the ER are indirectly regulated by TRIC channel activity, which mediates transmembrane K+ flux to maintain
electroneutrality across the ERmembrane. In fibroblasts and osteoblasts, ER-resident Ca2+-binding chaperones, including
BiP, CyPB, PDI and calreticulin (CRT), directly interact with collagen alpha chains (red polypeptides) to facilitate or catalyze
specific modifications required for assembly and folding. In the absence of TRIC-mediated K+ flux, Ca2+-dependent “cycling”
of these chaperones between inactive, sequestered forms and active, substrate-interacting forms, is dysregulated. Thus,
absence of TRIC-B alters ER luminal [Ca2+], affecting synthesis and secretion of collagen, as well as interactions of collagen-
specific chaperones with each other and with their substrate, resulting in abnormal collagen assembly and post-translational
modification. BiP, GRP78; CyPB, cyclophilin B; CRT, calreticulin; IP3R, inositol triphosphate receptor; LH1, lysyl hydroxylase
1; PDI, protein disulfide isomerase; SERCA2b, sarcoplasmic-endoplasmic reticulum Ca2+-ATPase isoform 2b; TRIC-B,
trimeric intracellular cation channel subtype B.
doi:10.1371/journal.pgen.1006156.g008
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multiple steps in type I collagen synthesis and modification in proband cells, placing type XIV
OI within the collagen-related paradigm of OI. Ca2+/K+ flux abnormalities can reasonably be
expected to affect synthesis and secretion of additional matrix components beyond collagen.
Furthermore, Ca2+/K+ flux abnormalities likely affect bone cell function, since intracellular cal-
cium signaling is known to control osteoblast proliferation and differentiation, as well as osteo-
clast survival and resorptive activity, through regulation of gene transcription [55–59].
Materials and Methods
Human subjects
This study was approved by the NICHD IRB (Protocol #04-CH-0077). Cells from Proband 3
were obtained as part of the diagnostic process. Written, informed consent was obtained from
all subjects or their respective guardians.
Cell culture
Proband and three independent normal control primary fibroblast (FB) cell lines were cultured
at 37°C and 5% CO2 in DMEM with GlutaMAX (Life Technologies) containing 10% fetal
bovine serum and 1% pen-strep. Primary osteoblast (OB) cultures were established from surgi-
cal bone chips of normal control and Proband 2. Following digestion of bone chips for 2 h at
37°C with 0.3 units/ml collagenase P in serum-free αMEM, osteoblasts were cultured in
αMEM supplemented with 10% fetal bovine serum and 1% pen-strep at 37°C and 8% CO2
[60]. For generation of conditioned media, cells were cultured in media containing 0.1% fetal
bovine serum and 100 μg/ml ascorbate for 24 h in the presence or absence of 50 μMMG132
(Sigma-Aldrich). For ER stress experiments, cells were cultured in media supplemented with
100 μg/ml ascorbate with or without N-[N-(N-Acetyl-L-leucyl)-L-leucyl]-L-norleucine
(ALLN, Sigma-Aldrich) for 8 h.
Mutation identification
Total RNA was extracted from fibroblast and osteoblast cultures in the presence or absence of
emetine (100 μg/ml) using TriReagent (Molecular Research Center) according to the manufac-
turer’s protocol. Total RNA was treated with DNA-free (Life Technologies) prior to further
analysis. Since the majority of cases of OI are caused by dominant mutations in COL1A1 and
COL1A2, molecular screening for a causative defect began with these genes. No sequence vari-
ants, however, were detected in cDNA obtained from proband fibroblast cultures.
Genomic DNA (gDNA) was prepared from fibroblasts or whole blood using the Puregene
DNA extraction kit (Qiagen). Additional molecular screening was performed on proband
genomic DNA utilizing Next Generation Sequencing (NGS) covering a panel of genes associ-
ated with autosomal dominant and recessive forms of OI (ALPL, BMP1, COL1A1, COL1A2,
CRTAP, FKBP10, IFITM5, LEPRE1, PLOD2, PPIB, SERPINF1, SERPINH1, SP7, TMEM38B
andWNT1; Connective Tissue Gene Tests).
For Proband 1, fibroblast gDNA (500 ng) was used to amplify the region surrounding the
putative deletion inclusive of exon 4 in TMEM38B (NG_032971.1), which was previously char-
acterized by Volodarsky et al [21]. A fully nested PCR was performed using 15 pmol primers
flanking exon 4, which are specific to the normal allele (WT-S, 5’-TGG TGA AAG GGA AGA
ATT GC-3’; WT-AS, 5’-GAG AAA CCC ACA GAG AAG GAA A-3’), and primers flanking
the deletion (Exon 3s, 5’-CCG CAT GAC CTA GTT TCC CAG GGC TAT TCA-3’; Intron 4as,
5’-CAA AGC AGG ATG AGG TTT GGA CAA CAG ACC-3’), 1% Perfect Match (Agilent
Technologies), 3% DMSO, and 1.0 U High Fidelity Platinum Taq polymerase (Life
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Technologies). After an initial 5 minute denaturation at 94°C, reactions were incubated for 35
cycles of 94°C for 1 min, 51°C for 30 sec and 72°C for 1 min, followed by 7 min at 72°C. PCR
products were then sequenced (Macrogen). Genomic DNA was unavailable for further testing
of the parents or siblings.
For Proband 2, NGS (Connective Tissue Gene Tests) identified only a single mutant allele,
which was verified by Sanger sequencing. Genomic DNA from the proband and his family
members was used to amplify the region surrounding exon 1 of TMEM38B by PCR. Reactions
contained 15 pmol primers (5’UTRs, 5’-TCT CCT ACT CCT CAC CGC-3’; Intron 1as, 5’-
CGA CTT AGA CGG TCC TCG-3’) and 1.25 U Amplitaq Gold (Life Technologies). Following
an initial 10 minute denaturation at 95°C, reactions were incubated for 40 cycles of 94°C for 30
sec, 54°C for 30 sec and 72°C for 30 sec, followed by 7 min at 72°C. PCR products were then
sequenced (Macrogen). The second mutant allele in Family 2 was detected by high-density tar-
geted (HDT) array, which suggested copy number variation (CNV) in the first two exons of
TMEM38B for the proband, his sibling and father (Connective Tissue Gene Tests). Based on
the molecular findings reported by Rubinato et al [22], heminested primers were designed to
amplify the region encompassing a 35 Kb region encompassing exons 1 and 2 of TMEM38B.
PCR amplification, using 15 pmol primers (5’BP-S, 5’-GCA GCC TCA ACC TCC TGG GCT
CAG ATG ATT-3’; 5’WT-AS, TAG GCC TGG CTG GTG GCT CAT GCC TGT AAT-3’;
3BP-AS, 5’-GCT TTT GAA ACT GAC CCA CCA GGG CTC TCT-3’) and the same condi-
tions described above, generated 216 bp and 339 bp fragments for the mutant and normal
alleles, respectively.
Proband 3 genomic DNA was amplified using 3% DMSO, 1.0 U High Fidelity Platinum
Taq polymerase (Life Technologies), and 15 pmol primers encompassing exon 4 of TMEM38B
(INT3-S, 5’-TTG ACA TGC TGG TGA AAG GGA AGA ATT GCA-3’; INT4-AS, 5’-CAG
CTA TAT TCC ACC CAC ATT TAA AGT CCC-3’). An initial 5 minute denaturation at 94°C
was followed by 35 cycles of 94°C for 1 min, 60°C for 30 sec and 72°C for 1 min, followed by 7
min at 72°C. Amplification products were then sequenced (Macrogen).
Analysis of gene expression
Gene transcript levels were quantitated by real-time RT-PCR following reverse-transcription
using a High Capacity cDNA Archive Kit and Taqman Assays on Demand (Life Technologies,
TMEM38A, Hs00225325_m1; TMEM38B, Hs00216531_m1; COL1A1, Hs00164004_m1;
FKBP10, Hs01000263_m1; PLOD1, Hs00609368_m1; PLOD2, Hs01118190_m1; PLOD3,
Hs01126617_m1; P4HB/PDI, Hs00168586_m1;HSPA5, Hs99999174_m1; PPIB,
Hs00168719_m1; ATP2A/SERCA2, Hs00544877_m1; ITPR1, Hs00181881_m1; RYR1,
Hs00166991_m1; GAPDH, Hs99999905_m1; ACTB, Hs99999903_m1; B2M,
Hs99999907_m1). Relative expression of genes of interest was measured in triplicate in 3 inde-
pendent cultures against 3 reference genes (ACTB, B2M and GAPDH). To validate gene expres-
sion levels in normal control fibroblast cell lines, transcript levels were determined
independently for each control cell line and compared to cDNA derived from pooled RNA
samples (S8 Fig). Gene expression in proband fibroblasts was then quantified relative to pooled
normal control fibroblast values. Gene transcripts in proband osteoblasts are expressed relative
to a single normal control primary osteoblast cell line.
Identification of TMEM38B splice variants in P1 mRNAwas performed as follows: DNase-
treated total RNA (1 μg) was reverse transcribed using an antisense primer (5’-AAC GGC
TGC TGC CAG CCA AAT AGC ATC CAA-3’) complementary to exon 6 of the TMEM38B
transcript (NM_018112.2) and murine leukemia virus (MuLV) reverse transcriptase (Life
Technologies). Subsequent PCR used the same antisense primer and a sense primer
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corresponding to exon 2 sequence (5’-GGA GCA GCT GCA TTG GCA TGG AAG AAT
CCT-3’). Reaction products were electrophoresed on 1.5% agarose gels and visualized with
ethidium bromide. Alternatively, spliced transcripts were purified by extraction of individual
gel bands using the QIAquick gel extraction kit (Qiagen), followed by cloning into plasmids
(TOPO TA cloning kit, Life Technologies) and sequencing using vector-specific primers. To
quantitate splice products, RT-PCR reactions were repeated in the presence of 2.5 μCi of
111TBq/mmol [α-32P] dCTP for 20 or 25 cycles. PCR products were electrophoresed on 6%
TBE gels and individual bands were quantitated by densitometry of autoradiographs.
For XBP1 splicing, 1 μg of DNase-treated total RNA was reverse-transcribed using the
SuperScript One-Step RT-PCR System (Life Technologies). The resulting cDNA was used as a
template for PCR amplification across the region of the XBP1 cDNA containing the intronic
target of IRE1α ribonuclease activity using 15 μM sense (5’-TCA GCT TTT ACG AGA GAA
AAC TCA TGG CCT-3’) and antisense primers (5’-AGA ACA TGA CTG GGT CCA AGT
TGT CCA GAA-3’). Following a 30 min incubation at 50°C, reactions were cycled 30 times at
94°C, 60°C and 72°C for 30 sec at each temperature. Reaction products were electrophoresed
on 6% TBE gels (Life Technologies) and visualized by ethidium bromide staining.
Western blot analysis
Fibroblast cultures were lysed in RIPA buffer (150 mMNaCl, 1% NP-40, 0.5% Na-deoxycho-
late, 0.1% SDS, 50 mM Tris, pH 7.4) supplemented with protease inhibitor cocktail (Sigma-
Aldrich). Protein concentration was determined using the BCA Protein Assay Kit (Thermo Sci-
entific). Samples (20 μg protein) were subjected to SDS-PAGE on 4–15% acrylamide gels
(BioRad) under denaturing conditions and transferred to nitrocellulose membranes. The mem-
branes were blocked overnight in 5% non-fat milk in TBST. After washing in TBST, mem-
branes were incubated overnight at 4°C in TBST containing 2.5% non-fat milk and primary
antibody (diluted 1:500–1000). After washing in 1X TBST, membranes were incubated with
the corresponding IRDye infrared secondary antibody (diluted 1:10,000) (LI-COR Biosci-
ences). Proteins were visualized using an Odyssey Infrared Imaging System (LI-COR Biosci-
ences) and quantitated using the Odyssey 3.0.30 software with normalization to actin levels.
The primary antibodies used include rabbit anti-TMEM38B (Thermo Fisher; PA5-20859),
mouse anti-TMEM38A (Abnova; H00079041-B01P), rabbit anti-IP3R1 (Novus Biologicals;
NB120-5908), rabbit anti-SERCA2 (Novus Biologicals; NBP1-59203), rabbit anti-GRP78
(Abcam; ab32618), mouse anti-FKBP65 (Abnova; H00060681-M13), rabbit anti-cyclophilin B/
PPIB (Abcam; ab16045), rabbit anti-PLOD1 (Abgent; AP12656c), rabbit anti-PLOD2 (Pro-
teintech; 21214-1-AP), rabbit anti-ATF4 (Proteintech; 10835-1-AP), mouse anti-ATF6 (Active
Motif; 40962), and mouse anti-PDI (Novus Biologicals; H00005034-B01P). Rabbit anti-α1(I)
C-telopeptide (LF68) was a generous gift from Larry Fisher, NIDCR, NIH. Rabbit (Santa Cruz
Biotechnology; sc-1616-R) and mouse (Sigma-Aldrich; A5441) anti-ACTIN antibodies were
used as loading controls. Western analyses were performed in duplicate on independent cul-
tures to ensure reproducibility.
[Ca2+]i measurements
For determination of [Ca2+] flux into the cytoplasm, normal control and proband fibroblasts
and osteoblasts were cultured in 96-well plates for 3 days prior to loading with 5 μM Fura-
2AM (Life Technologies) in HBSS for 30 min at 37°C in 5% CO2. The Ca
2+ transients were
recorded as the 340/380 nm ratio (R) of the resulting 510-nm emissions using a Mithras LB
940 plate reader (Berthold Technologies), as previously described [61]. Intracellular [Ca2+] was
calculated using the equation [Ca2+]i = Kd (R-Rmin)/(Rmax-R)(F
380
max/F
380
min), where Rmin is
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the ratio at zero [Ca2+], Rmax is the ratio when Fura-2 is completely saturated with Ca
2+,
F380min is the fluorescence at 380 nm for zero [Ca
2+], and F380max is the fluorescence at saturat-
ing [Ca2+] and Kd = 224 nM [62]. To stimulate Ca
2+ release, 200 μM of ATP or 2 μg/ml iono-
mycin was injected into cultures using the Mithras 940. For inhibition experiments, cells were
incubated for 30 min before analysis with either 100 μM 2-APB to block IP3R, or 100 nM thap-
sigargin for SERCA ER Ca2+ pump inactivation.
Endoplasmic reticulum luminal free [Ca2+] was quantified using D1ER, a cameleon class
calcium FRET sensor containing YFP and CFP, as previously described [25,26]. Normal and
proband fibroblasts (5 x 105 cells) were transfected with 2 μg D1ER or with 1 μg of pmaxGFP
plasmid by electroporation using a 4D-Nucleofector system (Lonza), seeded into covered
chamber slides and cultured at 37°C in 5% CO2 for 48 hr. Following a 30 min incubation in
Ca2+-free HBSS, cells were treated with 1 mM ATP to evoke transient depletion of ER calcium.
Cells were then treated with 5 μM ionomycin (Sigma) and 3 mM EGTA (Sigma) to obtain a
minimum ER calcium signal reference value. Images were obtained on a Zeiss 510 laser scan-
ning microscope using a 20x 0.8 NA objective. D1ER was excited at 405 nm. CFP emission was
collected at 420–480 nm and the FRET signal was collected at 505–550 nm. Ratios were calcu-
lated in ImageJ (v1.50i, NIH, USA) by first subtracting the background using the Rolling Ball
plugin (50 pixel radius, paraboloid) and filtering using a Gaussian blur (2 pixel radius) for each
image and then dividing the FRET image by the CFP image. The ratio was then normalized to
the average ratio obtained 6 frames before ATP application (R0). Rmin was determined 1 min
after ionomycin application from the new stable baseline using a 6-frame average. Calcium sig-
nal changes between baseline (before ATP treatment) and depletion (after ionomycin treat-
ment) were evaluated using ΔR = Rmin/R0−1.
Biochemical analysis of type I collagen
Steady-state collagen analysis was performed as previously described [63]. Normal control and
proband fibroblasts or osteoblasts were grown to confluence in 6-well culture dishes. Cells were
incubated with 437.5 μCi/ml of 3.96 TBq/mmol L-[2,3,4,5-3H] proline for 18 h prior to collec-
tion. Procollagens were precipitated overnight at 4°C with 176 mg/ml ammonium sulfate, pel-
leted by centrifugation at 37,000 x g, and digested with pepsin (50 μg/ml) for 4 h. Collagen alpha
chains were separated on 6% SDS-urea-polyacrylamide gels and visualized by autoradiography.
For analysis of collagen modification, confluent cell cultures were stimulated for collagen
synthesis in DMEM containing 0.1% FBS and 100 μg/ml ascorbate for three days, with daily
collection. Collected medium was buffered with 100 mM Tris-HCl, pH 7.4, and protease inhib-
itors were added to the following final concentrations: 25 mM EDTA, 0.02% NaN3, 1 mM phe-
nylmethylsulfonylfluoride, 5 mM benzamidine, and 10 mMN-ethylmaleimide. Procollagens
were then precipitated with 176 mg/ml ammonium sulfate overnight at 4°C and pelleted by
centrifugation at 16,000 x g for 2 h. Procollagens were resuspended in 0.5 M acetic acid and
digested with 0.1 mg/ml pepsin at 4°C overnight. Selective salt precipitation of type I collagen
with 0.9 M NaCl in 0.5 M acetic acid was performed twice, followed by dialysis against 5mM
acetic acid overnight and lyophilization for further analyses.
Differential Scanning Calorimetry (DSC) scans were performed as previously described
[64]. Thermograms were recorded in 0.2 M sodium phosphate, 0.5 M glycerol, pH 7.4, from 10
to 50°C at 0.125°C/min heating rates in a Nano III DSC instrument (Calorimetry Sciences
Corporation).
Amino acid analysis to quantify total 4-hydroxyproline, proline, 5-hydroxylysine and lysine
content of type I collagen was performed by high-pressure liquid chromatography (AIBiotech).
For determination of modification of specific residues pro-alpha chains of type I procollagen
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were resolved by SDS-PAGE, followed by in-gel trypsin digestion for analysis of targeted pep-
tides. Electrospray mass spectrometry was performed using an LTQ XL ion-trap mass spec-
trometer equipped with in-line liquid chromatography (Thermo Scientific) using a C4 5 μm
capillary column (300 μm × 150 mm; Higgins Analytical RS-15M3-W045). The LC mobile
phase consisted of buffer A (0.1% formic acid in MilliQ water) and buffer B (0.1% formic acid in
3:1 acetonitrile:n-propanol v/v). The LC sample stream was introduced into the mass spectrom-
eter by electrospray ionization (ESI) with a spray voltage of 4 kV. Proteome Discoverer software
(Thermo Scientific) was used for peptide identification using the NCBI protein database.
Procollagen chain association
Procollagen chain incorporation was followed as previously described [65]. Procollagen alpha
chains were labeled with a pulse of 140 μCi/ml of 3.96 TBq/mmol L-[2,3,4,5-3H] proline for 80
min, then chased with DMEM containing 10% serum, 50 μg/ml ascorbic acid and 10 mM pro-
line for the time intervals specified. Samples were ethanol precipitated, separated on 5%
SDS-Urea-polyacrylamide gels and visualized by autoradiography.
Collagen synthesis and secretion kinetics
For pulse-chase assays, performed in triplicate, normal control and proband fibroblasts or oste-
oblasts were grown to confluence in 6-well culture dishes [66]. For each cell line, two wells
were used for cell counts. Cells were labeled for 4 h with 1.75 μCi [14C]-proline and then chased
with fresh medium containing 2 mM cold proline. Medium and cell layer procollagens were
harvested at the indicated times, digested with pepsin and precipitated with 2M NaCl. Samples
were loaded for equivalent cell number on 3–8% Tris-acetate gels. Collagen alpha chains were
quantitated by densitometry and expressed as the percent secreted at each time point, as deter-
mined by (media)/(cell + media) x 100.
Alternatively, cells were grown to confluence in 75 cm2 culture flasks and incubated in phe-
nol red-free DMEM (Life Technologies) containing 0.1% FBS and 100 μg/ml ascorbic to gener-
ate conditioned media. After 24 h, media was collected, supplemented with protease inhibitor
cocktail (Sigma-Aldrich), and concentrated using Amicon Ultra-4 centrifugal filter devices
(Millipore). Total collagen derived from each flask was quantitated using the Sircol Soluble
Collagen Assay (Biocolor Ltd) according to the manufacturer’s instructions. Immediately fol-
lowing media collection, cultures were trypsinized and collected for determination of cell count
from each flask. Data is expressed as amount of collagen secreted per cell per hour and were
generated from 3 fibroblast and osteoblast cultures per proband, 3 replicates of the normal
osteoblast control cultures, and 6 normal control fibroblast cultures.
Procollagen pericellular processing
Processing of procollagens secreted by fibroblasts was examined by labeling confluent cells
with 260 μCi/ml of 3.96 TBq/mmol L-[2,3,4,5-3H] proline for 24 h and then chased with
DMEM containing 2 mM non-radioactive proline and 10% fetal bovine serum. Media from
independent wells were harvested at 24-h intervals over a 5-day period as previously described,
precipitated with ammonium sulfate, electrophoresed on 6% polyacrylamide-urea-SDS gels,
and visualized by autoradiography [67].
Collagen matrix deposition
Normal control and proband primary fibroblasts were grown to confluence and stimulated
every other day for 14 days with fresh DMEM containing 10% FBS and 100 μg/ml ascorbic
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acid, as described [68], and then labeled for 24 h with 437.5 μCi/ml L-[2,3,4,5-3H] proline.
Matrix collagens were sequentially extracted at 4°C, with neutral salt for newly incorporated
collagen, acetic acid for collagens with acid-labile cross-links, and pepsin digestion for colla-
gens with mature cross-links [69]. All fractions were electrophoresed on 6% polyacrylamide-
urea-SDS gels. Samples were loaded for equivalent densitometry signal, and the total signal for
each fraction calculated by adjusting the signal by the total volume of that fraction.
Statistical analysis
Data were analyzed using an unpaired Student t-test with two-tailed analysis and considered
statistically significant at p< 0.05.
Supporting Information
S1 Fig. TMEM38B Bedouin founder mutation results in minimal in-frame transcripts due
to alternative splicing. (A) Characterization of alternative splicing in P1 fibroblasts, including
4 out-of-frame and 1 in-frame transcript. Arrows represent positions of primers used for
RT-PCR amplification. () represents positions of premature termination codons in alternative
transcripts. (B)Quantitation of splice forms from Proband 1 fibroblast RNA. Densitometric
analysis of RT-PCR products, amplified for 20 or 25 cycles, demonstrates the in-frame variant
(, 368 bp) is 8% of the signal of the expected 639 bp product from normal control fibroblast
mRNA.
(TIF)
S2 Fig. Relative expression of TRIC isoforms and ER calcium release channels. (A) Relative
mRNA transcript levels of TMEM38A and TMEM38B in normal and proband fibroblasts and
osteoblasts. Transcript levels were normalized to three reference genes (ACTB, B2M and
GAPDH) and are expressed relative to normal control fibroblast TMEM38B transcripts. (B)
Levels of RYR1 and ITPR1 transcripts in normal and proband fibroblasts and osteoblasts, ver-
sus normal fibroblast control ITPR1 expression. Relative expression was determined using the
comparative CT method (ΔΔCt, http://www3.appliedbiosystems.com/cms/groups/mcb_
support/documents/generaldocuments/cms_042380.pdf). , p< 0.01.
(TIF)
S3 Fig. Decreased Ca2+ mobilization in TRIC-B deficient cells. (A) Ionomycin-stimulated
Ca2+ release to deplete all intracellular stores, followed by ATP-stimulated IP3R-mediated Ca
2+
release, demonstrates absence of replenishment of ER Ca2+ stores in P1 fibroblasts. (B)
Decreased Ca2+ release and delayed return to baseline following ionomycin-stimulated Ca2+
release suggest global dysregulation of intracellular Ca2+ homeostasis. Ca2+ efflux was
completely blocked in the presence of the IP3R inhibitor 2-APB (dashed lines).
(TIF)
S4 Fig. Altered ER [Ca2+] does not delay cyclophilin B-mediated collagen folding. Assay for
intracellular folding of type I collagen in Proband 1 (P1) fibroblast cultures versus normal con-
trol (C) fibroblasts. The equivalent rate of trypsin-resistant collagen alpha chains suggests nor-
mal functioning of cyclophilin B-mediated peptidyl-prolyl cis-trans isomerization, the rate-
limiting step in collagen folding. Data represents the average from three experiments.
(TIF)
S5 Fig. Pulse-chase analysis of pericellular procollagen processing. Procollagens secreted by
Proband 1 (OI) and normal control (C) fibroblasts were collected at 1-day intervals and sepa-
rated by SDS-Urea PAGE to follow their processing by pericellular propeptidases. There is an
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increase in the fraction of type I procollagen molecules that are resistant to amino propeptide
removal (pN-α1(I) and pN-α2(I), denoted by ) in proband cell cultures at all timepoints.
(TIF)
S6 Fig. Pulse-chase analysis of collagen secretion. Type I collagen secretion kinetics are
equivalent in Proband 1 (P1) and normal control (C) fibroblast cultures. However, comparison
of the quantity of collagen in cell and media fractions at each timepoint demonstrate a nearly
40% decrease in the amount of collagen in proband samples.
(TIF)
S7 Fig. Amount of type I collagen deposited into extracellular matrix in culture is decreased
in the absence of TRIC-B.Normal control (C) and Proband 1 (P1) fibroblasts were grown to
confluence and stimulated for collagen synthesis for 2 weeks with ascorbate. Following a 24-hr
pulse of labeled collagen, secreted collagens were collected and extracellular matrix was serially
extracted with neutral salt (NS), acetic acid (AA) for immaturely crosslinked and pepsin (P) for
maturely crosslinked collagen isolation. Samples were loaded for type I collagen balance. Note
the difference in the pepsin-soluble fraction of P1 matrix versus normal control matrix; the rel-
ative increase in P1 type III collagen (α1(III)3) suggests a decrease in the amount of type I colla-
gen capable of matrix incorporation.
(TIF)
S8 Fig. Validation of normal primary fibroblast control cell lines. The relative expression of
genes of interest in three independent normal control fibroblast cell lines (NL C1, C2 and C3)
was evaluated by real-time RT-PCR. Expression levels were compared to values obtained for
pooled cDNA (NL pool) derived from each control cell line. Only COL1A1 expression varied
significantly among the 3 normal control cell lines. , p< 0.05.
(TIF)
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